There are still barriers to mental health care, in both the medical and outside worlds, noted Debra Delaney, MSN, FNP-BC, primary care nurse practitioner at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute.
In some ways, there are still barriers to mental health care, in both the medical and outside worlds, noted Debra Delaney, MSN, FNP-BC, primary care nurse practitioner at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute; the more it is talked about, acceptance will grow, she added.
Transcript
Why is it important to address barriers to mental health, as highlighted by the COVID-19 pandemic, and can you discuss how stress and mental health overlap with oncology care?
There still are barriers in some ways. I look at the world—the medical world and outside world—and there is a stigma attached to it, even though we're talking more about it than we ever have. Even patients who come to me and they tell me that they're crying intermittently, and I say, “Well, you know, that seems to be one of the signs of depression.” And we talk about supportive care, journaling. We talk about communicating with friends and family and surrounding each other with support. And when I bring up the topic of medications, patients will shut me down immediately and say, “I do not want to medication.” And I'm fine with that. That's fine. What I say is, “We do need to talk about this because crying every day is interfering with your activity of daily living, and it's not supposed to happen.
The stigma is still there, and we're trying to work with it. The more we talk about it, I think the more it will be accepted. It's slow, and patients don't like to take medications to begin with. There are a lot of patients who [say], “I'm going to get my blood pressure under control with exercise and weight loss,” and that's great and I support that 100%—and I support patients who want supportive care first. Also, counseling can be beneficial for patients who are struggling mentally.
In the oncology world, the oncology diagnosis is such a heavy, heavy diagnosis to hear. Immediately, I think people go to a really dark area when somebody says, “This looks like it's cancer.” That plays on the mental health issues that may already be there, it brings them to the forefront. I see that a lot in my practice, and I talk to patients. Again, I go over supportive care mechanisms: “Let's do journaling, surround yourself with friends, it's okay to sit and cry for a few minutes, and then we have to try to work our way through this.” I can refer them to psycho-oncology, I can refer them to outside counseling if they want for cognitive behavioral therapy, and we can discuss medications at some point when they're ready.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More